Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Great Minds Members Event - Decoding Dementia: Biomarkers, Big Data, and the Future of Diagnosis

This special Great Minds event brought together leading experts to explore how biomarkers, big data, and artificial intelligence are transforming dementia research and diagnosis. Our distinguished panel discussed the remarkable developments in blood-based biomarkers over the past five years, examined their clinical validity and readiness for NHS implementation, and explored the potential of AI in dementia care. The event provided valuable insights into how these innovations are shaping the future of personalised medicine and early detection in dementia.

Thank you to everyone who joined us for this insightful event exploring how biomarkers, big data, and artificial intelligence are transforming dementia research and diagnosis.

Our panel of expert speakers included:

Prof John Gallacher - Director, Dementias Platform UK, University of Oxford
What has big data told us about dementia? Developments over the past 5 years

Prof James Rowe - Cambridge University
The validity and utility of blood-based biomarkers in Alzheimer's and non-Alzheimer's dementias

Prof Vanessa Raymont - Associate Director, DPUK, University of Oxford
Are we ready for blood-based biomarkers in the NHS?

Dr Ivan Koychev - Great Minds Lead, Imperial College London
Artificial intelligence for dementia - what could it do?

What was covered:

  • Latest developments in big data research and its impact on understanding dementia
  • The validity and utility of blood-based biomarkers for Alzheimer's and non-Alzheimer's dementias
  • Clinical readiness and implementation of biomarkers in the NHS
  • The potential of artificial intelligence in dementia diagnosis and care
  • Panel discussion addressing questions from researchers and the dementia community

Missed the event or want to watch it again? The full recording is now available HERE.

** Great Minds Live is for people who have joined our GREAT MINDS register. However, we welcome and encourage others to attend and to consider becoming members of Great Minds.